PATENT CLAIM ANALYSIS

Application Number: 15752004
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-08
Patent Classification: ["514", "210180"]

Abstract:
Disclosed herein, in part, are fumagillol compounds and methods of use in treating medical disorders, such as obesity. Pharmaceutical compositions and methods of making fumagillol compounds are provided. The compounds are contemplated to have activity against methionyl aminopeptidase 2.

Claim (Index 9):
The compound of any one of  claims 1 - 8 , wherein the compound is represented by Formula I.

Metadata:
- Claim Count in Document: 41.0
- Percentile: 88.0
- Lexical Diversity: 1.40625
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15827074', '15354834', '15796519', '14974033', '15769414']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8594000291102997
- 35 USC 102 Novelty (BERT): 0.6092312830794776
- Combined Prediction Score: 0.8343831545072175
- Mean Citation Score: 462.634208
- Max Citation Score: 606.9383
- Similarity Product: 396.4288907551049

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test